"I am delighted to welcome Emmet and Mike to the HMS team," said Bill Lucia, HMS' chairman and CEO. "Both are accomplished and well-connected healthcare leaders who know how to navigate the complexities and ever-changing landscape of our healthcare system. They will be instrumental in executing our growth plans, while helping our customers contain costs and effectively engage their members in their own health."About HMSHMS is a leading provider of cost containment solutions to the U.S. healthcare market. Our solutions improve financial and health outcomes for organizations at risk. Using innovative technology and powerful data analytics, we help clients reduce costs, increase quality and achieve regulatory compliance. As a result of our services, clients save billions of dollars annually. Visit us at www.hms.com or follow us on Twitter at @HMSHealthcare. Contact:Elizabeth Bonet, HMS972 894 8405 firstname.lastname@example.org
IRVING, Texas, Jan. 08, 2018 (GLOBE NEWSWIRE) -- HMS (NASDAQ:HMSY) today announced that Emmet O'Gara and Michael Cole, two veteran healthcare executives, have joined HMS in newly created positions to help accelerate the company's growth initiatives. This includes driving growth through its consumer engagement business, care management platform and analytics offerings. Emmet O'Gara, formerly senior vice president and chief revenue officer for Cota—a healthcare data and analytics company—joins HMS as executive vice president, Total Population Management (TPM). O'Gara will oversee all aspects of the company's TPM business development, product innovation and delivery capabilities. His responsibilities include leadership of Eliza, a health engagement business HMS acquired in April 2017. Based in Eliza's headquarters in Danvers, Massachusetts, O'Gara reports to HMS Chairman and CEO Bill Lucia. O'Gara brings more than 25 years of experience in the healthcare payer, provider and employer markets. Prior to Cota, he served as senior vice president and general manager of Payer and Provider Solutions at MedeAnalytics, a leading healthcare analytics company. During his eight-year tenure, O'Gara drove new sales, expanded existing accounts and accelerated revenue growth. He previously held key leadership roles at Blue Cross Blue Shield of Massachusetts, Accenture and Cigna Healthcare. Michael Cole, formerly national vice president for health plans at Quest Diagnostics, joins HMS as senior vice president, Commercial Markets. He is responsible for driving and executing growth strategies for HMS' commercial business, including cross-sales of Eliza consumer engagement solutions. He also will oversee customer engagement and account management for the company's 325 health plan clients. Based in Chicago, Illinois, Cole reports to Doug Williams, HMS' president of Markets and Product. With 27 years in the healthcare industry, Cole has a proven track record of generating growth and leading large-scale operations. Prior to Quest Diagnostics, he spent 10 years at UnitedHealthcare (UHC), where he last served as national vice president, Employer and Individual Markets—a major business segment with 7.6 million covered members. Cole also served as chief operating officer for UnitedHealthcare of Illinois. Previously, he spent 12 years at Cigna Healthcare of Illinois, where he was a new business manager leading sales strategy and execution for multiple employee healthcare services.